Methylphenidate derivatives and uses of them

Details Methylphenidate derivatives and uses of them Methylphenidate derivatives and uses of them

2008-10-29

2011-12-13

O Dell, David K (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C514S330000

Reexamination Certificate

active

08076485

ABSTRACT:
The present invention provides methods of using compounds of formula I:and salts and prodrugs thereof, wherein n, R1and R2are defined herein. The invention also provides certain novel compounds of formula I and pharmaceutical compositions comprising them.

REFERENCES:
patent: 2507631 (1950-05-01), Hartmann et al.
patent: 2957880 (1960-10-01), Rometsch et al.
patent: 5407926 (1995-04-01), Clark
patent: 5658955 (1997-08-01), Hitzig
patent: 5859249 (1999-01-01), Seido et al.
patent: 5908850 (1999-06-01), Zeitlin et al.
patent: 6025502 (2000-02-01), Winklter et al.
patent: 6060463 (2000-05-01), Freeman
patent: 6127385 (2000-10-01), Midha et al.
patent: 6210705 (2001-04-01), Mantelle et al.
patent: 6395752 (2002-05-01), Midha et al.
patent: 6486177 (2002-11-01), Zeldis et al.
patent: 7267949 (2007-09-01), Richards et al.
patent: 2005/0101582 (2005-05-01), Lyons et al.
patent: 2005/0192290 (2005-09-01), Melamed
patent: 2006/0183773 (2006-08-01), Bar-Or et al.
patent: 2006/0189655 (2006-08-01), Bar-Or et al.
patent: WO 99/16439 (1999-04-01), None
patent: WO 99/36403 (1999-07-01), None
patent: WO 00/59880 (2000-10-01), None
patent: WO 00/74680 (2000-12-01), None
patent: WO 01/30337 (2001-05-01), None
patent: WO 01/68053 (2001-09-01), None
patent: WO 03/037247 (2003-05-01), None
patent: WO 2004/043480 (2004-05-01), None
patent: WO 2004/058289 (2004-07-01), None
patent: WO 2005/000203 (2005-01-01), None
Dunnick et al., “Decreased incidence of spontaneous mammary gland neoplasms in female F344 rats treated with amphetamine, methylphenidate, or codeine,” Cancer Letters, 1996, vol. 102(1-2), pp. 77-83.
Cruse et al., Illustrated Dictionary of Immunology (2nd edition, Taylor & Francis Group, CRC Press LLC, 2003), p. 475.
Krupp et al., “Fatigue in multiple sclerosis,” Curr Neurol Neurosci Rep, 2001, vol. 1(3), pp. 294-298.
Auci et al. “Methylphenidate and the immune system,” J Am Acad Child Adolcesc Psychiatry 1997, 36(8): 1015-1016.
Breitbart et al., “A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease”, Arch Inern Med 2001, 161(3): 411-20, Abstract only, PubMed ID: 11176767.
Challman et al., “Methylphenidate: its pharmacology and uses”, Mayo Clin Proc 2000, 75: 711-721.
Deutsch et al., “Synthesis and pharmacology of potential cocaine antagonists. 2. Structure—activity relationship studies of aromatic ring-substituted methylphenidate analogs,”, J Med Chem 1996, 39:: 1201-1209.
Dunnick et al., “Decreased incidence of spontaneous mammary gland neoplasms in female F344 rats treated with amphetamine, methylphenidate, or codence”, Cancer Ltt 19996, 102(1-2): 77-83; Erratum in Cancer Lett 1996 105(1): 121-122, Abstract only, PubMed ID:8603383.
Dunnick et al., “Experimental studies on long-term effects of methylphenidate hydrochloride,” Toxicology 1995, 103(2): 77-84 Abstract only, PubMed ID: 8545847.
Gatley et al., “Affinities of Methylphenidate derivative for dopamine, norepinephrine and seotonin transporters,” Life Sciences 1996, 58(12): 231-239.
Happe, “Excessive daytime sleepiness and sleep disturbances in patients with neurological diseases: epidemiology and management”, Drugs 2003, 63(24): 2725-2737 Abstract only, PubMed ID 14664652.
Haran “Beyond just tired: figuring out MS-related fatigue”, available on the Worldwide Web at http://www.understandingsms.com/ms/articles/ms—beyondtired.asp, downloaded on May 7, 2006.
Krupp et al., “Fatigue in multiple sclerosis,” Curr Neurol Neurosci Rep 2001, 1(3): 294-298 Abstract only, PubMed ID 11898532.
Leonard et al., “Methylphenidate: a review of its neuropharmacological, neuropsycological and adverse clinical effects,” Human Psychopharmacol Clin Exp 2004, 19:151-180.
Natl Toxicol Program Tech Rep Ser, “NTP toxicology and carcinogenesis studies of methylphenidate hydrochloride (CAS No. 298-59-9) in F344/N rats and B6C3F1 mice (feed studies),” 1995, 439:1-299 Abstract only, PubMed ID 12595924.
Pan et al., “Binding of bromine-substituted analogs of methylphenidate to monoamine transporters,” Euro J Pharmacol 1994, 264:177-182.
Patrick et al., “Synthesis and pharmacology of hydroxylated metabolites of methylphenidate,” J Med Chem 1981, 24(1): 1237-1240.
Teo et al., “D-methylphenidate is non-genotoxic in in vitro and in vivo assays,” Mutat Res 2003, 537(1): 67-79 Abstract only, PubMed ID 12742508.
Thai et al, “Asymmetric synthesis and pharmacology of methylphenidate and its para-substituted derivatives”, J Med Chem 1998, 41: 591-601.
Thai et al., “Comparative pharmacokinetics and tissue distribution of the d-enantiomers of para-substituted methylphenidate analogs,” Drug Metabolism and Disposition 1999, 27(6): 645-650.
Vargas et al., “Neuroglial activation and neuroinflammation in the brain of patients with autism”, Annal Neurol, Early View (Articles online in advance of print), Wiley InterScience::Article Full Text HTML, available on the World Wide Web at http://www3.interscience.wile.com/cgi-bin/fulltext/109793289/main.html,ftx—abs, downloaded on Nov. 15, 2004.
Vigano et al., “Methylphenidate for the management of somatization in terminal cancer patients,” J Pain Symptom Manage 1995, 10(2): 167-170 Abstract only, PubMed ID 7730689.
Wayment et al., “Effects on methylphenidate analogues on phenethylamine substrates for the striatal dopamine transporter: potential as amphetamine antagonists?” J Neurochem 1999, 72(3): 1266-1274 Abstract only, PubMed ID 10037500.
“InteliHealth: Multiple Sclerosis,” available on the World Wide Web at http://www.intelihealth.com/IH/ihtIH/WSIHW000/9339/10372.html, downloaded on May 7, 2006.
Ritalin, available on the World Wide Web at http://ms.about.com/od/treatment/a/Ritalin.htm, downloaded on May 7, 2006.
Bruera et al., Patient-Controlled Methylphenidate for the Management of Fatigue in Patients With Advanced Cancer: A Preliminary Report, Journal of Oncology, vol. 21, No. 23, Dec. 2003, pp. 4439-4443.
Davies et al., “Synthesis of Methylphenidate Analogues and their Binding Affinities at Dopamine and Serotonin Transport Sites”, Bioorganic & Medicinal Chemistry Letters, 2004, vol. 14, pp. 1799-1802.
Rozans et al., “Palliative Uses of Methylphenidate in Pateints With Cancer: A Review”, J. Clin. Oncology, Jan. 1, 2002, vol. 20, No. 1, pp. 335-339.
Krim, Lori, Thesis (Ph.D. in Chemistry) (2001), University Of Pennsylvania, Chemistry Library Reading Room (Call No. QD001 2001.K92), University Microfilms Order No. 3031684, ISBN 0-493-44179-4, 762 pages.
Search Report for International (PCT) Patent Application No. PCT/US2006/002008, mailed Sep. 21, 2006.
Written Opinion for International (PCT) Patent Application No. PCT/US2006/002008, mailed Sep. 21, 2006.
International Preliminary Report on Patentability for International (PCT) Patent Application No. PCT/US2006/002008, mailed Aug. 2, 2007.

Affiliated with

Also associated with

Rating

Methylphenidate derivatives and uses of them does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methylphenidate derivatives and uses of them, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methylphenidate derivatives and uses of them will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4301412